CaV3.1 blockers such as pimozide and mibefradil are shown to be antiproliferative in adipose models of breast cancer (Bertolesi et al. 2002), an observation we now confirm for 3T3-L1 adipogenesis. This evidence concerns the gene CACNA1G and breast carcinoma.